Education
About Us
Working with TipRanks
Follow Us
Fuji Pharma Co., Ltd. (JP:4554)
:4554
Total Valuation
Fuji Pharma Co., Ltd. has a market cap or net worth of ¥44.87B. The enterprise value is ¥59.09B.
Market Cap¥44.87B
Enterprise Value¥59.09B
Share Statistics
Fuji Pharma Co., Ltd. has 24,891,100 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding24,891,100
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Fuji Pharma Co., Ltd.’s return on equity (ROE) is 0.06 and return on invested capital (ROIC) is 4.66%.
Return on Equity (ROE)0.06
Return on Assets (ROA)0.03
Return on Invested Capital (ROIC)4.66%
Return on Capital Employed (ROCE)0.08
Revenue Per Employee31.17M
Profits Per Employee1.81M
Employee Count1,658
Asset Turnover0.55
Inventory Turnover1.53
Valuation Ratios
The current PE Ratio of Fuji Pharma Co., Ltd. is 14.9. Fuji Pharma Co., Ltd.’s PEG ratio is -0.24.
PE Ratio14.9
PS Ratio0.73
PB Ratio0.80
Price to Fair Value0.80
Price to FCF9.88
Price to Operating Cash Flow0.00
PEG Ratio-0.24
Income Statement
In the last 12 months, Fuji Pharma Co., Ltd. had revenue of 51.68B and earned 3.00B in profits. Earnings per share was 122.93.
Revenue51.68B
Gross Profit19.29B
Operating Income4.99B
Pretax Income4.00B
Net Income3.00B
EBITDA8.30B
Earnings Per Share (EPS)122.93
Cash Flow
In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.
Operating Cash Flow0.00
Free Cash Flow0.00
Free Cash Flow per Share0.00
Dividends & Yields
Fuji Pharma Co., Ltd. pays an annual dividend of ¥25.5, resulting in a dividend yield of 2.48%
Dividend Per Share¥25.5
Dividend Yield2.48%
Payout Ratio37.01%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.80
52-Week Price Change26.99%
50-Day Moving Average1.67K
200-Day Moving Average1.44K
Relative Strength Index (RSI)71.34
Average Volume (3m)86.41K
Important Dates
Fuji Pharma Co., Ltd. upcoming earnings date is Feb 5, 2026, TBA (Not Confirmed).
Last Earnings DateNov 11, 2025
Next Earnings DateFeb 5, 2026
Ex-Dividend Date―
Financial Position
Fuji Pharma Co., Ltd. as a current ratio of 1.55, with Debt / Equity ratio of 65.96%
Current Ratio1.55
Quick Ratio0.86
Debt to Market Cap0.71
Net Debt to EBITDA2.86
Interest Coverage Ratio15.12
Taxes
In the past 12 months, Fuji Pharma Co., Ltd. has paid 1.00B in taxes.
Income Tax1.00B
Effective Tax Rate0.25
Enterprise Valuation
Fuji Pharma Co., Ltd. EV to EBITDA ratio is 7.40, with an EV/FCF ratio of 16.08.
EV to Sales1.19
EV to EBITDA7.40
EV to Free Cash Flow16.08
EV to Operating Cash Flow10.59
Balance Sheet
Fuji Pharma Co., Ltd. has ¥6.91B in cash and marketable securities with ¥32.14B in debt, giving a net cash position of -¥25.23B billion.
Cash & Marketable Securities¥6.91B
Total Debt¥32.14B
Net Cash-¥25.23B
Net Cash Per Share-¥1.01K
Tangible Book Value Per Share¥1.35K
Margins
Gross margin is 40.18%, with operating margin of 9.66%, and net profit margin of 5.81%.
Gross Margin40.18%
Operating Margin9.66%
Pretax Margin7.74%
Net Profit Margin5.81%
EBITDA Margin16.06%
EBIT Margin8.38%
Analyst Forecast
The average price target for Fuji Pharma Co., Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast12.01%
EPS Growth Forecast-51.38%